• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普罗帕酮在肾功能不全和肾衰竭中的处置

Propafenone disposition in renal insufficiency and renal failure.

作者信息

Burgess E, Duff H, Wilkes P

机构信息

Department of Medicine, University of Calgary, Alberta, Canada.

出版信息

J Clin Pharmacol. 1989 Feb;29(2):112-3. doi: 10.1002/j.1552-4604.1989.tb03296.x.

DOI:10.1002/j.1552-4604.1989.tb03296.x
PMID:2715367
Abstract

The pharmacokinetics of a single intravenous dose of propafenone were studied in subjects with normal renal function (n = 5), renal insufficiency (n = 5), and renal failure (n = 3). No difference in central volume of distribution, total ischemic clearance or terminal half-life existed. None of the pharmacokinetic parameters examined correlated to creatinine clearance. Within the confines of the small number of patients studied, there does not appear to be any effect of renal insufficiency or failure on single-dose propafenone disposition.

摘要

在肾功能正常(n = 5)、肾功能不全(n = 5)和肾衰竭(n = 3)的受试者中研究了单次静脉注射普罗帕酮的药代动力学。分布中心容积、总缺血清除率或终末半衰期均无差异。所检测的药代动力学参数均与肌酐清除率无关。在所研究的少数患者范围内,肾功能不全或肾衰竭似乎对单次剂量普罗帕酮的处置没有任何影响。

相似文献

1
Propafenone disposition in renal insufficiency and renal failure.普罗帕酮在肾功能不全和肾衰竭中的处置
J Clin Pharmacol. 1989 Feb;29(2):112-3. doi: 10.1002/j.1552-4604.1989.tb03296.x.
2
Influence of renal function on the steady-state pharmacokinetics of the antiarrhythmic propafenone and its phase I and phase II metabolites.肾功能对抗心律失常药物普罗帕酮及其Ⅰ期和Ⅱ期代谢产物稳态药代动力学的影响。
Eur J Clin Pharmacol. 1995;48(3-4):279-83. doi: 10.1007/BF00198312.
3
Hemodialysis removal of propafenone.血液透析清除普罗帕酮。
Pharmacotherapy. 1989;9(5):331-3. doi: 10.1002/j.1875-9114.1989.tb04145.x.
4
Disposition of famotidine in renal insufficiency.
J Clin Pharmacol. 1987 Oct;27(10):782-7. doi: 10.1002/j.1552-4604.1987.tb02996.x.
5
Pharmacokinetics of cefoxitin in normal subjects and in patients with renal insufficiency.头孢西丁在正常受试者和肾功能不全患者中的药代动力学。
Rev Infect Dis. 1979 Jan-Feb;1(1):118-26. doi: 10.1093/clinids/1.1.118.
6
Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.肾衰竭、类风湿关节炎及老年对二氟尼柳药代动力学的影响。
Eur J Clin Pharmacol. 1989;36(2):165-74. doi: 10.1007/BF00609190.
7
Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.西多福韦在肾功能不全及持续性非卧床腹膜透析或高通量血液透析患者中的药代动力学。
Clin Pharmacol Ther. 1999 Jan;65(1):21-8. doi: 10.1016/S0009-9236(99)70118-9.
8
Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.慢性肾衰竭对接受和未接受血液透析患者利多卡因药代动力学的不同影响。
Clin Pharmacol Ther. 2006 Dec;80(6):597-606. doi: 10.1016/j.clpt.2006.08.020.
9
Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function.替莫西林(BRL 17421)在肾功能正常和受损受试者中的药代动力学。
J Antimicrob Chemother. 1983 Jul;12(1):47-58. doi: 10.1093/jac/12.1.47.
10
Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites.肾功能不全对环磷酰胺及其某些代谢产物药代动力学的影响。
Eur J Clin Pharmacol. 1981;19(6):443-51. doi: 10.1007/BF00548589.

引用本文的文献

1
Systematic and quantitative assessment of the effect of chronic kidney disease on CYP2D6 and CYP3A4/5.慢性肾脏病对CYP2D6和CYP3A4/5影响的系统定量评估
Clin Pharmacol Ther. 2016 Jul;100(1):75-87. doi: 10.1002/cpt.337. Epub 2016 Mar 7.
2
Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.普罗帕酮。对其药理学、药代动力学及在心律失常治疗中的应用的重新评估。
Drugs. 1993 Jan;45(1):85-130. doi: 10.2165/00003495-199345010-00008.
3
Influence of renal function on the steady-state pharmacokinetics of the antiarrhythmic propafenone and its phase I and phase II metabolites.
肾功能对抗心律失常药物普罗帕酮及其Ⅰ期和Ⅱ期代谢产物稳态药代动力学的影响。
Eur J Clin Pharmacol. 1995;48(3-4):279-83. doi: 10.1007/BF00198312.
4
Clinical pharmacokinetics of propafenone.
Clin Pharmacokinet. 1991 Jul;21(1):1-10. doi: 10.2165/00003088-199121010-00001.
5
Pharmacokinetics of newer drugs in patients with renal impairment (Part II).
Clin Pharmacokinet. 1991 May;20(5):389-410. doi: 10.2165/00003088-199120050-00004.